• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

UCB:BB

65.7900 EUR 0.7700 1.18%

As of 11:35:00 ET on 12/19/2014.

Snapshot for UCB SA (UCB)

Open: 65.3600 Day's Range: 65.3600 - 66.6800 Volume: 346,317
Previous Close: 65.0200 52wk Range: 50.1100 - 75.6200 1-Yr Rtn: +26.47%

Stock Chart for UCB

No chart data available.
  • UCB:BB 65.7900
  • 1D
  • 1M
  • 1Y
65.0200
Interactive UCB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UCB

Current P/E Ratio (ttm) 49.0970
Estimated P/E(12/2014) 31.6298
Relative P/E vs. BEL20 1.2516
Earnings Per Share (EUR) (ttm) 1.3400
Est. EPS (EUR) (12/2014) 2.0800
Est. PEG Ratio 1.8633
Market Cap (M EUR) 12,796.53
Shares Outstanding (M) 194.51
30 Day Average Volume 270,636
Price/Book (mrq) 2.6604
Price/Sale (ttm) 3.8969
Dividend Indicated Gross Yield 1.58%
Cash Dividend (EUR) 0.7800
Dividend Ex-Date 04/29/2014
5 Year Dividend Growth 2.48%
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UCB

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for UCB

UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders and inflammatory diseases. UCB operates worldwide.

Roch F DoliveuxCo-Chief Executive OfficerJean-Christophe TellierExec VP:Biopharma/CEO-Elect
Detlef ThielgenExec VP/CFOIsmail KolaExec VP/Pres:Newmedicines
More Company Profile & Key Executives for UCB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil